Ernexa Therapeutics Inc. Other Sundry Liabilities, Noncurrent
Ernexa Therapeutics Inc. (ERNA) had Other Sundry Liabilities, Noncurrent of $48.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Notes › Other Liabilities › Other Liabilities and Financial Instruments Subject to Mandatory Redemption
us-gaap:OtherSundryLiabilitiesNoncurrent · last filed 2022-11-14
- 2022-09-30: Other Sundry Liabilities, Noncurrent $48.00K.
- 2021-12-31: Other Sundry Liabilities, Noncurrent $48.00K.
| Period end | Other Sundry Liabilities, Noncurrent |
|---|---|
| 2022-09-30 | $48.00K 10-Q · filed 2022-11-14 |
| 2021-12-31 | $48.00K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |